These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Kamisango KI; Saiki I; Tanio Y; Kobayashi S; Yamamura Y Infect Immun; 1980 Sep; 29(3):1193-6. PubMed ID: 7429634 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs. Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020 [No Abstract] [Full Text] [Related]
9. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs. Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554 [TBL] [Abstract][Full Text] [Related]
10. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine. Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117 [No Abstract] [Full Text] [Related]
11. Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Okumura H; Saiki I; Tanio Y; Kiso M; Hasegawa A; Yamamura Y Infect Immun; 1981 Jun; 32(3):1305-8. PubMed ID: 7251169 [TBL] [Abstract][Full Text] [Related]
12. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents. Chedid L; Audibert F; Johnson AG Prog Allergy; 1978; 25():63-105. PubMed ID: 362430 [No Abstract] [Full Text] [Related]
13. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier. Chedid L; Parant M; Parant F; Audibert F; Lefrancier F; Choay J; Sela M Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6557-61. PubMed ID: 293743 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs. Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372 [TBL] [Abstract][Full Text] [Related]
15. Biological studies of lipophilic MDP-derivatives incorporated in liposomes. Jolivet M; Sache E; Audibert F Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities. Hasegawa A; Okumura H; Kiso M; Azuma I; Yamamura Y Carbohydr Res; 1980 Feb; 79(1):C20-3. PubMed ID: 7357567 [No Abstract] [Full Text] [Related]
17. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil. Carelli C; Audibert F; Chedid L Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs. Kiso M; Kaneda Y; Okumura H; Hasegawa A; Azuma I; Yamamura Y Carbohydr Res; 1980 Feb; 79(1):C17-9. PubMed ID: 7357566 [No Abstract] [Full Text] [Related]
19. [Immunoadjuvant activities of bacterial cell wall components--with special reference to the effects of administration with various vehicles]. Kinoshita F Osaka Daigaku Shigaku Zasshi; 1978 Jun; 23(1):141-57. PubMed ID: 397324 [No Abstract] [Full Text] [Related]
20. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP). Adam A; Souvannavong V; Lederer E Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370 [No Abstract] [Full Text] [Related] [Next] [New Search]